Last Posted: Aug 08, 2019
- CMS finalizes long-sought rules for Medicare CAR-T coverage
N Florko, Stat News, August 7, 2019 - The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
Brahmer Julie R et al. Journal for immunotherapy of cancer 2018 6(1) 75 - Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: a single institution, retrospective cohort study.
Tan Irena et al. Translational lung cancer research 2019 Jun 8(3) 258-267 - Artificial intelligence reveals new breast cancer types that respond differently to treatment
Institute of Cancer Research, August 2019 - Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc Marine et al. Frontiers in immunology 2019 1505 - Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer.
Zhang Xianyu et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Jul - CAR T-Cell Therapy: A Microcosm for the Challenges Ahead in Medicare.
Jacobson Caron et al. JAMA 2019 Jul - Advancing cancer immunotherapy: a vision for the field
NFCC de Miranda et al, Genome Medicine, Sepetmber 29, 2019 - [Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5].
Qiu Haibo et al. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2018 Feb 21(2) 160-164 - Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer.
Zhu Jason et al. Urologic oncology 2019 Jul
.png)
No hay comentarios:
Publicar un comentario